{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:07:29Z","timestamp":1778940449321,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,20]],"date-time":"2027-01-20T00:00:00Z","timestamp":1800403200000},"content-version":"am","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Clinical Trials Network","doi-asserted-by":"publisher","award":["1UG1DA049444"],"award-info":[{"award-number":["1UG1DA049444"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001923","name":"Health Services Research Programme","doi-asserted-by":"publisher","award":["19\\u2013001"],"award-info":[{"award-number":["19\\u2013001"]}],"id":[{"id":"10.13039\/501100001923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007181","name":"US Department of Veterans Affairs Quality Enhancement Research Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CIN 13\\u2013414"],"award-info":[{"award-number":["CIN 13\\u2013414"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004866","name":"New York State Office of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011959","name":"Institute of Development and Economic Alternatives","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011959","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.josat.2026.209895","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:34:43Z","timestamp":1768581283000},"page":"209895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differences in buprenorphine initiation and retention for opioid use disorder between primary care and substance use disorder specialty care settings"],"prefix":"10.1016","volume":"183","author":[{"given":"Nicholas R.","family":"Livingston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Malte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline C.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hildi J.","family":"Hagedorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy J.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.209895_bb0005","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2024"},{"key":"10.1016\/j.josat.2026.209895_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108548","article-title":"Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting","volume":"131","author":"Bailey","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209895_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112663","article-title":"Clinical pharmacist practitioners prescribing of buprenorphine for opioid use disorder","volume":"271","author":"Baylis","year":"2025","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2026.209895_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","article-title":"Medication treatment of opioid use disorder","volume":"87","author":"Bell","year":"2020","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2026.209895_bb0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3102\/10769986025001060","article-title":"On the adaptive control of the false discovery rate in multiple testing with independent statistics","volume":"25","author":"Benjamini","year":"2000","journal-title":"Journal of Educational and Behavioral Statistics"},{"issue":"5","key":"10.1016\/j.josat.2026.209895_bb0030","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3122\/jabfm.2019.05.190012","article-title":"Predictors of medication-assisted treatment initiation for opioid use disorder in an interdisciplinary primary care model","volume":"32","author":"Cantone","year":"2019","journal-title":"The Journal of the American Board of Family Medicine"},{"key":"10.1016\/j.josat.2026.209895_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13722-025-00562-1","article-title":"Buprenorphine discontinuation and utilization of psychosocial services: A national study in the Veterans Health Administration","volume":"20","author":"Cleary","year":"2025","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"10.1016\/j.josat.2026.209895_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/00952990.2020.1832507","article-title":"Aims, development, and early results of an interdisciplinary primary care initiative to address patient vulnerabilities","volume":"47","author":"Codell","year":"2021","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2026.209895_bb0045","series-title":"VA\/DoD Clinical Practice Guideline for the Management of Substance Use Disorders","author":"Department of Veterans Affairs (VA) and Department of Defense (DoD)","year":"2021"},{"issue":"6","key":"10.1016\/j.josat.2026.209895_bb0050","first-page":"1273","article-title":"The Behavioral Model for Vulnerable Populations: Application to medical care use and outcomes for homeless people","volume":"34","author":"Gelberg","year":"2000","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2026.209895_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103715","article-title":"A mixed methods study of provider factors in buprenorphine treatment retention","volume":"105","author":"Gertner","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.josat.2026.209895_bb0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Article commentary: Stepped care for opioid use disorder train the trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities","volume":"41","author":"Gordon","year":"2020","journal-title":"Substance Abuse"},{"issue":"8","key":"10.1016\/j.josat.2026.209895_bb8000","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapediatrics.2017.0745","article-title":"Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001, 2014","volume":"171","author":"Hadland","year":"2017","journal-title":"JAMA Pediatrics"},{"issue":"1\u20132","key":"10.1016\/j.josat.2026.209895_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2012.12.008","article-title":"Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes","volume":"131","author":"Haddad","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.209895_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108504","article-title":"National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness","volume":"132","author":"Han","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2026.209895_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1037\/1541-1559.5.3.228","article-title":"Predictors of initiation and engagement in VA substance use disorder (SUD) treatment","volume":"5","author":"Harris","year":"2008","journal-title":"Psychological Services"},{"key":"10.1016\/j.josat.2026.209895_bb0090","article-title":"Buprenorphine Receipt and Retention for Opioid Use Disorder Following an Initiative to Increase Access in Primary Care","volume":"10-1097","author":"Hawkins","year":"2023","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.209895_bb0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11606-022-07456-x","article-title":"Trends in health service utilization after enrollment in an interdisciplinary primary care clinic for veterans with addiction, social determinants of health, or other vulnerabilities","volume":"38","author":"Jones","year":"2023","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2026.209895_bb0100","article-title":"Factors associated with long-term retention in buprenorphine-based addiction treatment programs: A systematic review","volume":"1-9","author":"Kennedy","year":"2022","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.209895_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13722-025-00568-9","article-title":"Implementing buprenorphine for opioid use disorder in veterans health administration primary care: A qualitative analysis","volume":"20","author":"Lott","year":"2025","journal-title":"Addiction Science & Clinical Practice"},{"issue":"6","key":"10.1016\/j.josat.2026.209895_bb0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/ajad.12553","article-title":"Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration","volume":"26","author":"Manhapra","year":"2017","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2026.209895_bb0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugalcdep.2015.12.035","article-title":"Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration","volume":"160","author":"Manhapra","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2026.209895_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108717","article-title":"Opioid use disorder treatment for people experiencing homelessness: A scoping review","volume":"224","author":"McLaughlin","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2026.209895_bb0125","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-069488","article-title":"Changes in Synthetic Opioid\u2013Involved Youth Overdose Deaths in the United States: 2018\u20132022","volume":"155","author":"Miller","year":"2025","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.josat.2026.209895_bb0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3122\/jabfm.2022.01.210292","article-title":"Integrating buprenorphine treatment for opioid use with primary care is associated with greater retention in treatment","volume":"35","author":"Mirer","year":"2022","journal-title":"The Journal of the American Board of Family Medicine"},{"key":"10.1016\/j.josat.2026.209895_bb0135","series-title":"Behavioral Health and Substance Use, Spring 2021 Cycle Technical Report","article-title":"Continuity of pharmacotherapy for opioid use disorder (OUD)","volume":"2021","author":"National Quality Forum. Quality ID #3175","year":"2022"},{"issue":"11","key":"10.1016\/j.josat.2026.209895_bb0140","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3928\/00220124-20151020-02","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised publication guidelines from a detailed consensus process. The","volume":"46","author":"Ogrinc","year":"2015","journal-title":"Journal of Continuing Education in Nursing"},{"issue":"3","key":"10.1016\/j.josat.2026.209895_bb0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2026.209895_bb0150","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1353\/hpu.2015.0077","article-title":"Needing primary care but not getting it: the role of trust, stigma and organizational obstacles reported by homeless veterans","volume":"26","author":"O\u2019Toole","year":"2015","journal-title":"Journal of Health Care for the Poor and Underserved"},{"issue":"11","key":"10.1016\/j.josat.2026.209895_bb0155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2026.209895_bb0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addbeh.2018.03.012","article-title":"Correlates of specialty substance use treatment among adults with opioid use disorders","volume":"86","author":"Romo","year":"2018","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.josat.2026.209895_bb0165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1377\/hlthaff.2019.01085","article-title":"Impact of long-term buprenorphine treatment on adverse health care outcomes in Medicaid: The impact of longer treatment on health care outcomes for opioid use disorder within a key population of Medicaid enrollees","volume":"39","author":"Samples","year":"2020","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2026.209895_bb0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209895_bb0175","series-title":"Center for Behavioral Health Statistics and Quality","article-title":"Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21\u201307\u201301-003, NSDUH Series H-56)","author":"Substance Abuse and Mental Health Services Administration","year":"2021"},{"key":"10.1016\/j.josat.2026.209895_bb0180","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11524-025-00966-z","article-title":"Improving Cross-Sector Collaborations between Healthcare and Housing: Challenges and Strategies Identified by Unhoused People with Complex Health Needs","volume":"102","author":"Tiderington","year":"2025","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.josat.2026.209895_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6963-9-217","article-title":"Trends in health services utilization, medication use, and health conditions among older adults: A 2-year retrospective chart review in a primary care practice","volume":"9","author":"Vegda","year":"2009","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.josat.2026.209895_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108848","article-title":"Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic","volume":"141","author":"Wakeman","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.209895_bb0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in office based opioid treatment with buprenorphine","volume":"74","author":"Weinstein","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2026.209895_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps","volume":"39","author":"Wyse","year":"2018","journal-title":"Substance Abuse"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:13:20Z","timestamp":1778937200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"alternative-id":["S2949875926000159"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.209895","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in buprenorphine initiation and retention for opioid use disorder between primary care and substance use disorder specialty care settings","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.209895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209895"}}